THE STRESS RESPONSE OF CRITICAL ILLNESS

J.I. Epstein; Michael J. Breslow

doi:10.1016/s0749-0704(05)70037-3

Home SearchPaper Details

THE STRESS RESPONSE OF CRITICAL ILLNESS

J.I. Epstein, Michael J. Breslow

Elsevier BV (1999) • Volume 15, Issue 1, Pages 17-33

PDF Available

Abstract

The integrated stress response to tissue trauma is crucial for the maintenance of homeostasis. An exaggerated or prolonged response may be detrimental in compromised patients. Knowledge of the involved afferent pathways will suggest therapeutic interventions that may modulate the intensity of the stress response. Described are these concepts as they relate to perioperative medicine.

Quick Actions

Read Full Paper

Publication Info

DOI

10.1016/s0749-0704(05)70037-3

Language

English

Topic

Cardiac

Keywords

Medicine, Homeostasis, Perioperative, Endocrine system, Resuscitation, Hormone, Organ dysfunction, Surgical stress, Stressor, Norepinephrine, Epinephrine, Anesthesia, Intensive care medicine, Internal medicine, Sepsis, Psychiatry

Published

January 1, 1999

Citations

150 citations

FWCI

2.32

External Resources

DOI Link OpenAlex

THE STRESS RESPONSE OF CRITICAL ILLNESS

Abstract

Quick Actions

Publication Info

External Resources

Suggested Papers

Integrating gender-based violence first-line response into family planning and antenatal care services: an assessment of feasibility, appropriateness and acceptability to healthcare providers in Sokoto and Ebonyi States, Nigeria

Third-generation versus first-generation EGFR tyrosine kinase inhibitors in Asian patients with advanced EGFR mutant non-small cell lung cancer: a meta-analysis of randomized controlled trials

Premortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell death

Suggested Papers

Suggested Papers

Integrating gender-based violence first-line response into family planning and antenatal care services: an assessment of feasibility, appropriateness and acceptability to healthcare providers in Sokoto and Ebonyi States, Nigeria

Third-generation versus first-generation EGFR tyrosine kinase inhibitors in Asian patients with advanced EGFR mutant non-small cell lung cancer: a meta-analysis of randomized controlled trials

Premortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell death